Finance

Beta
Lists
TN8:ETR
Thermo Fisher Scientific Inc
€412.00
-1.93%
(-8.10) 1D
Jun 5, 5:35:53 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TN8...
Open
€415.70
High
€419.70
Low
€410.40
Mkt. cap
175.70B
Avg. vol.
307.00
Volume
155.00
52-wk high
€548.90
52-wk low
€336.25
No. of employees
125K
Open
€415.70
High
€419.70
Low
€410.40
Mkt. cap
175.70B
Avg. vol.
307.00
Volume
155.00
52-wk high
€548.90
52-wk low
€336.25
No. of employees
125K
News stories
From sources across the web
Profile
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD. It ranked 104th on the Fortune 500 list based on its 2024 annual revenue of $42.879 billion. Wikipedia
About Thermo Fisher Scientific Inc
CEOMarc N. Casper
Employees125K
Founded1956
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websitethermofisher.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.86B
11.12B
12.22B
11.00B
Cost of goods sold
6.44B
6.53B
7.17B
6.56B
Cost of revenue
6.44B
6.53B
7.17B
6.56B
Research and development expenses
352.00M
346.00M
356.00M
336.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.12B
2.10B
2.24B
2.14B
Operating expense
2.48B
2.45B
2.46B
2.48B
Total operating expenses
8.92B
8.98B
9.63B
9.04B
Operating income
1.94B
2.14B
2.59B
1.97B
Other non operating income
-14.00M
-32.00M
-32.00M
-15.00M
EBT including unusual items
1.71B
1.83B
2.12B
1.73B
EBT excluding unusual items
1.82B
2.03B
2.44B
1.83B
Income tax expense
92.00M
207.00M
153.00M
70.00M
Effective tax rate
5.38%
11.32%
7.21%
4.06%
Other operating expenses
-
-
-135.00M
1.00M
Net income
1.62B
1.62B
1.96B
1.65B
Net profit margin
14.90%
14.53%
16.08%
15.00%
Earnings per share
5.36
5.79
6.57
5.44
Interest and investment income
297.00M
234.00M
258.00M
233.00M
Interest expense
-404.00M
-347.00M
-365.00M
-354.00M
Net interest expenses
-107.00M
-113.00M
-107.00M
-121.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.61B
2.82B
3.31B
2.70B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer